- 29
- 0
- 约4.62万字
- 约 28页
- 2016-03-13 发布于贵州
- 举报
多发性骨髓瘤血il-6的测定及其临床意义
摘 要
多发性骨髓瘤血清IL-6的测定及其临床意义
研究生:黄琴 导师:王晓敏副教授
摘 要
目的:探讨多发性骨髓瘤患者血清白介素 6 水平变化及其检测的临床意义。方
法:对105 例多发性骨髓瘤患者(其中31 例维吾尔族、74 例汉族)和70 例正常对
照用EILSA 法测定血清IL-6 的水平,分析不同临床分期MM 患者血清IL-6 水平变
化。结果:MM 组IL-6 水平明显高于正常对照组(P0.05 );Ⅲ期MM 患者IL-6 水
平高于Ⅰ期(P0.05 );Ⅲ期IL-6 水平高于Ⅱ期(P0.05 );Ⅰ期和Ⅱ期间IL-6 水平
差异无统计学意义(P0.05 );维吾尔族与汉族MM 患者血清IL-6 水平无显著差异
(P0.05 )。结论:检测 IL-6 的水平可作为MM 临床分期,疗效及预后判断的有效
指标之一。抑制IL-6 的生物学功能,从而为MM 的临床治疗提供新的策略和途径可
作为MM 靶向治疗。
关键词:多发性骨髓瘤 白细胞介素6
1
新疆医科大学医学硕士学位论文
The Clinical Significance of the Change of Interleikin-6
Level In Multiple Myeloma
Prostgraduate :Huang Qin Supervisor:Wang Xiaomin Professor
Abstract
Objective:To investigate the clinical significance of the change of interleukin-6(IL-6)
level in multiple myeloma(MM). Methods:105MM patients,including 31Vighur
patients,74Han patients and 70 control. The serum IL-6 level was determined by
ELISA.Results: The MM patients had significantly higher IL-6 serum levels than the
control(P0.05).The IL-6 serum levels in stage Ⅲ were highest in all
stages(P0.05).There was no difference(P0.05) of the IL-6 serum levels between
stage Ⅰ and stage Ⅱ. There was no difference in the level of interleukin-6 between
Vighur patients and Han patients(P0.05).Conclusion : Monitoring the level of IL-6 is
useful in estimating the therapeutic efficancy and prognosis for the patients with MM.
Key word multiple myeloma, interleukin-6,
Key words: multiple myeloma; interleukin-6
2
原创力文档

文档评论(0)